Devin Schaffer
Consejero General en GENEDX HOLDINGS CORP. .
Origen de la red de primer grado Devin Schaffer.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Medical/Nursing Services | 21 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Devin Schaffer a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member | |
STANDARD BIOTOOLS INC. | Medical Specialties | Director/Board Member | |
Genomatica, Inc.
Genomatica, Inc. BiotechnologyHealth Technology Genomatica, Inc. designs and develops biotechnology products. It offers metabolic engineering for renewable production of commodity chemicals. The company was founded by Bernhard O. Palsson and Christophe H. Schilling in 1998 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
INVITAE CORPORATION | Medical/Nursing Services | Director/Board Member Investor Relations Contact Corporate Officer/Principal Corporate Officer/Principal | |
Rho Capital Partners, Inc.
Rho Capital Partners, Inc. Investment ManagersFinance Rho Capital Partners, Inc. (Rho Capital Partners) is a venture capital firm founded in 1981 by Joshua Ruch. The firm is headquartered in New York. | Investment Managers | Founder | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Miami University | College/University | Undergraduate Degree | |
Yale University | College/University | Corporate Officer/Principal | |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Medical Specialties | Director/Board Member | |
The Rockefeller University | College/University | Director/Board Member | |
Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
OPKO HEALTH, INC. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
National Institute of Mental Health | General Government | Corporate Officer/Principal | |
AMDeC Foundation, Inc. | Director/Board Member | ||
New York Genome Center
New York Genome Center Miscellaneous Commercial ServicesCommercial Services New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Verana Health, Inc.
Verana Health, Inc. Packaged SoftwareTechnology Services Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Pennsylvania State University College of Medicine | College/University | Doctorate Degree | |
Columbia University School of the Arts | College/University | Director/Board Member | |
Cancan Health | Director/Board Member | ||
ABSCI CORPORATION | Biotechnology | Director/Board Member | |
Imagen Technologies, Inc.
Imagen Technologies, Inc. Packaged SoftwareTechnology Services Imagen Technologies, Inc. operates as a medical technology company that develops and offers devices for the prevention of diagnostic errors. The company was founded by Alexander Dresner, Robert Lindsey, Thomas Stuart Hotchkiss and Sumit Chopra in 2015 and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
Genome Medical, Inc.
Genome Medical, Inc. Information Technology ServicesTechnology Services Genome Medical Holding Co. operates tele genomics platform which allows genetic experts to consult with patients and physicians across the country. The firm specializes in genomics, genetics, precision medicine, medical practice, personalized medicine, genetic counseling, DNA and genome. The company was founded by Lisa J. Alderson, Robert C. Green and Randal W. Scott in 2016 and is headquartered in South San Francisco, CA. | Information Technology Services | Director/Board Member | |
Gene Matters LLC
Gene Matters LLC Packaged SoftwareTechnology Services Gene Matters LLC engages in the provision of genetic counseling services. It serves genetic counselors, management team, and advisors. The company was founded by Jill Davies in 2016 and is headquartered in Minneapolis, MN. | Packaged Software | Director/Board Member | |
DNA Script SAS
DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal Director/Board Member President Director/Board Member | |
TENAYA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
Sexton Biotechnologies, Inc.
Sexton Biotechnologies, Inc. Medical SpecialtiesHealth Technology Sexton Biotechnologies, Inc. operates biotechnology company which develops and sales of bio-production tools for cell and gene therapy. The company is headquartered in Indianapolis, IN. | Medical Specialties | Director/Board Member | |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Prominex, Inc. (California)
Prominex, Inc. (California) Medical SpecialtiesHealth Technology Prominex, Inc. manufactures molecular diagnostic assays for infectious disease testing. The company was founded by Paul Thomas and Paul Gargan in 2017 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
C2i Genomics, Inc.
C2i Genomics, Inc. Packaged SoftwareTechnology Services C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
Genematters LLC
Genematters LLC Internet Software/ServicesTechnology Services GeneMatters LLC operates as a digital technology platform that provides genomic medicine delivery services. The company is based in Minneapolis, MN. | Internet Software/Services | Director/Board Member | |
2SEVENTY BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Mnemo Therapeutics SAS
Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
STANDARD BIOTOOLS INC. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
EQRX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Leyden Labs
Leyden Labs BiotechnologyHealth Technology Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands. | Biotechnology | Director/Board Member | |
IDRx, Inc.
IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
CastleVax, Inc.
CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Biotechnology | Director/Board Member | |
The Mount Sinai Health System, Inc.
The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal |
Estadísticas
Internacional
Estados Unidos | 47 |
Francia | 4 |
Países Bajos | 2 |
Sectorial
Health Technology | 21 |
Consumer Services | 8 |
Commercial Services | 7 |
Technology Services | 7 |
Health Services | 5 |
Operativa
Director/Board Member | 136 |
Corporate Officer/Principal | 34 |
Independent Dir/Board Member | 33 |
Chief Executive Officer | 15 |
Undergraduate Degree | 14 |
Las relaciones más conectadas
Insiders | |
---|---|
Eli Casdin | 48 |
Keith Meister | 43 |
Joshua Ruch | 33 |
Richard Pfenniger | 21 |
Jason Ryan | 13 |
Dennis Charney | 11 |
Emily Leproust | 11 |
Rachel Sherman | 10 |
Katherine Stueland | 10 |
Kareem Saad | 10 |
Karen White | 8 |
Tricia Truehart | 5 |
Chen Rong | 5 |
Kevin Feeley | 5 |
Melanie Duquette | 4 |
- Bolsa de valores
- Insiders
- Devin Schaffer
- Conexiones Empresas